North America Diagnostic Imaging Systems Market to Witness Robust Growth in Coming Years
According to the Centers for Disease Control and Prevention (CDC), six in ten adults in the U.S. are suffering from at least one chronic disease like diabetes, cancer, heart disease, or stroke. Moreover, the U.S. registers 1.7 million cancer cases and approximately 600,000 deaths due to cancer, annually, making it the second leading cause of death in the nation. Besides, incidences of type-2 diabetes, cancer, cardiovascular diseases (CVDs), and chronic obstructive pulmonary disease (COPD) are increasing in North America. The rising incidences of these diseases have increased the adoption of diagnostic imaging systems in the region.
North America Diagnostic Imaging Systems Market Research Report -Industry Size, Share Analysis and Growth Forecast till 2024
Moreover, hospitals and diagnostic imaging centers in North America are adopting these diagnostic imaging systems in large numbers, due to the growing awareness among people regarding the benefits of early diagnosis and early symptoms of diseases. The governments in the region are conducting awareness programs to educate people about the early diagnosis of diseases, such as tuberculosis, arthritis, breast cancer, cardiovascular diseases, lung cancer, and diabetes, and the use of innovative diagnostic systems to dragonize these diseases, at an early stage. These boost the demand for diagnostic imaging systems in the region.
For example, in November 2018, GE Healthcare announced its plan to partner with Veteran Affairs (VA) Puget Sound Healthcare System, to increase the adoption of 3D imaging in healthcare. Similarly, Shimadzu Medical Systems USA, in January 2019, acquired Core Medical Imaging Inc. to amplify its healthcare business in North America. In the same vein, Shimadzu Medical Systems USA, one of the leading players in the North American diagnostic imaging systems market, acquired Core Medical Imaging Inc., in January 2019, to amplify its business in North America.
Thus, the widening portfolio of the diagnostic imaging devices is expected to propel the demand for such systems in foreseeable future. This will, in turn, help in improving the healthcare system of North America.